NIH Director Page NIH Health Information Page NIH Impact NIH Fact Sheets NIH Social Media and Outreach
EurekAlert! - National Institutes of Health  



NIH Main


NIH Research News


Funded News

  For News & Research
  NIH Videos
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
  Additional Resources
  NIH Home Page

About NIH

  NIH Health Information
  Pub Med
  More News and Events Sources
  NIH News and Events, Special Interest
  RSS Feed RSS Feed
  Back to EurekAlert!


Department of Health and Human Services

News from the National Institutes of Health

Funded News

Key: Meeting M      Journal J      Funder F

Showing releases 3051-3075 out of 3759.

<< < 118 | 119 | 120 | 121 | 122 | 123 | 124 | 125 | 126 | 127 > >>

Public Release: 16-Sep-2014
Lancet Oncology
Improved risk identification will aid fertility preservation in young male cancer patients
A study led by St. Jude Children's Research Hospital investigators has found the chemotherapy dose threshold below which male childhood cancer survivors are likely to have normal sperm production. The study appears in Sept. 17 edition of the journal Lancet Oncology.
NIH/National Cancer Institute, American Lebanese Syrian Associated Charities

Contact: Carrie Strehlau
St. Jude Children's Research Hospital

Public Release: 16-Sep-2014
Slimy fish and the origins of brain development
Lamprey -- slimy, eel-like parasitic fish with tooth-riddled, jawless sucking mouths -- are rather disgusting to look at, but thanks to their important position on the vertebrate family tree, they can offer important insights about the evolutionary history of our own brain development, suggests a recent study done at Caltech.
National Institutes of Health, Stowers Institute for Medical Research

Contact: Deborah Williams-Hedges
California Institute of Technology

Public Release: 16-Sep-2014
Journal of Medical Internet Research
Do wearable lifestyle activity monitors really work?
Wearable electronic activity monitors hold great promise in helping people to reach their wellness goals. These increasingly sophisticated devices help the wearers improve their wellness by constantly monitoring their activities and bodily responses through companion computer programs and mobile apps. Given the large market for these devices, researchers at the University of Texas Medical Branch at Galveston analyzed 13 of these devices to compare how the devices and their apps work to motivate the wearer.
National Institutes of Health, US Department of Education, Agency for Healthcare Research and Quality, American Heart Association

Contact: Donna Ramirez
University of Texas Medical Branch at Galveston

Public Release: 16-Sep-2014
BioMed Central Biology
Healthy humans make nice homes for viruses
The same viruses that make us sick can take up residence in and on the human body without provoking a sneeze, cough or other troublesome symptom, according to new research at Washington University School of Medicine in St. Louis.
NIH/National Human Genome Research Institute

Contact: Caroline Arbanas
Washington University School of Medicine

Public Release: 16-Sep-2014
Researchers studying improving physician opioid prescribing
Boston University School of Medicine researcher Dr. Jeffrey Samet and Dr. Carlos Del Rio from Emory University were recently awarded a five year, $5 million grant from the National Institute of Drug Abuse for their project titled: Improving Physician Opioid Prescribing for Chronic Pain in HIV-infected Persons.
NIH/National Institute of Drug Abuse

Contact: Gina DiGravio
Boston University Medical Center

Public Release: 16-Sep-2014
Wistar and Penn Medicine collaborate on $12.1 million SPORE grant in melanoma
The Wistar Institute's Meenhard Herlyn, D.V.M., D.Sc., is the principal investigator on a $12.1 million Special Program of Research Excellence (SPORE) grant, a prestigious National Cancer Institute collaborative grant that brings together researchers at Wistar and the University of Pennsylvania to develop new melanoma therapies. The goal of this SPORE is to translate fundamental laboratory discoveries into new therapeutics that will benefit patients of melanoma and other skin cancers.
NIH/National Cancer Institute

Contact: Greg Lester
The Wistar Institute

Public Release: 16-Sep-2014
Journal of Neuroscience
Hey1 and Hey2 ensure inner ear 'hair cells' are made at the right time, in the right place
Two Johns Hopkins neuroscientists have discovered the 'molecular brakes' that time the generation of important cells in the inner ear cochleas of mice. These 'hair cells' translate sound waves into electrical signals that are carried to the brain and are interpreted as sounds. If the arrangement of the cells is disordered, hearing is impaired.
Whitehall Foundation, NIH/National Institute on Deafness and other Communication Disorders

Contact: Catherine Kolf
Johns Hopkins Medicine

Public Release: 16-Sep-2014
Rehabilitation Psychology
Kessler Foundation scientists link slowed processing speed with executive deficits in MS
Kessler Foundation researchers have published a study supporting the role of slowed processing speed in the executive deficits found in individuals with multiple sclerosis. 'Does slowed processing speed account for executive deficits in multiple sclerosis? Evidence from neuropsychological performance and structural neuroimaging,' was published online ahead of print on Aug. 18 by Rehabilitation Psychology. MS cognitive research should focus on two key domains -- processing speed and memory.
NIH/National Institute on Disability & Rehabilitation Research, National Institutes of Health, National MS Society

Contact: Carolann Murphy
Kessler Foundation

Public Release: 16-Sep-2014
Cell Stem Cell
Scientists create therapy-grade stem cells using new cocktail to reprogram adult cells
Researchers at the Hebrew University of Jerusalem have developed a new cocktail that coaxes adult cells to become pluripotent stem cells of a high enough quality to be used in therapeutic applications. Their research showed that using a different combination of reprogramming factors can produce a much higher quality result, delivering fewer colonies of iPSCs of which 80 percent passed the toughest pluripotency test.
Israeli Centers of Research Excellence Program, Kirschstein National Research Service Award, National Institutes of Health, National Science Foundation, Chapman Foundation, Florence Brill Graduate Student Fellowship

Contact: Dov Smith
The Hebrew University of Jerusalem

Public Release: 16-Sep-2014
Journal of the National Cancer Institute
Lactation linked to reduced estrogen receptor-negative, triple-negative breast cancer risk
Women who have had children (parous women) appear to have an increased risk of developing estrogen receptor-negative breast cancer, the subtype that carries a higher mortality rate and is more common in women of African ancestry. A similar relationship was found for triple-negative breast cancer. However, the association between childbearing and increased risk of estrogen receptor-negative and triple-negative breast cancer was largely confined to the women who had never breastfed.
NIH/National Cancer Institute

Contact: Jenny Eriksen Leary
Boston University Medical Center

Public Release: 16-Sep-2014
ASTRO's 56th Annual Meeting
Prostate cancer patients who receive hypofractionated RT report consistent QoL
Prostate cancer patients who received hypofractionated radiation therapy reported that their quality of life, as well as bladder and bowel function were at similar levels before and after radiation therapy, according to research presented today at the American Society for Radiation Oncology's 56th Annual Meeting.
National Institutes of Health

Contact: Michelle Kirkwood
American Society for Radiation Oncology

Public Release: 16-Sep-2014
PLOS Medicine
Point-of-care CD4 testing is economically feasible for HIV care in resource-limited areas
A study by Massachusetts General Hospital investigators, working in collaboration with colleagues in Mozambique and South Africa, indicates that routine use of point-of-care CD4 testing at the time of HIV diagnosis would be cost effective in countries where health care and other resources are severely limited.
NIH/National Institute of Allergy and Infectious Disease, UK Department for International Development, Clinton Health Access Initiative

Contact: Noah Brown
Massachusetts General Hospital

Public Release: 16-Sep-2014
Nature Communications
Human faces are so variable because we evolved to look unique
Why are human faces so variable compared to other animals, from lizards and penguins to dogs and monkeys? Two UC Berkeley scientists, Michael Nachman and postdoctoral fellow Michael Sheehan, analyzed human faces and the genes that code for facial features and found a high variability that could only be explained by selection for variable faces, probably because of the importance of social interactions in human relationships and the need for humans to be recognizable.
National Institutes of Health

Contact: Robert Sanders
University of California - Berkeley

Public Release: 16-Sep-2014
Translational Psychiatry
First blood test to diagnose depression in adults
The first blood test to diagnose major depression in adults has been developed, providing the first objective, scientific diagnosis for depression. The test also predicts who will benefit from cognitive behavioral therapy, offering the opportunity for more effective, individualized therapy. The test also showed the biological effects of the therapy, the first measurable, blood-based evidence of the therapy's success and showed who is vulnerable to recurring episodes of depression.
National Institutes of Health

Contact: Marla Paul
Northwestern University

Public Release: 16-Sep-2014
Imaging identifies asymptomatic people at risk for stroke
Imaging can be a cost-effective way to identify people at risk for stroke who might benefit from aggressive intervention, according to a new modeling study.
National Institutes of Health

Contact: Linda Brooks
Radiological Society of North America

Public Release: 15-Sep-2014
Psychological Science
Study first to use brain scans to forecast early reading difficulties
UC San Francisco researchers have used brain scans to predict how young children learn to read, giving clinicians a possible tool to spot children with dyslexia and other reading difficulties before they experience reading challenges.
NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development, Flora Family Foundation, UCSF Catalyst Award, UCSF Resource Allocation Program, Brain & Behavior Research Foundation Young Investigator Award, Stanford University Lucile

Contact: Juliana Bunim
University of California - San Francisco

Public Release: 15-Sep-2014
Scientists discover RNA modifications in some unexpected places
Deploying sophisticated high-throughput sequencing technology, dubbed ψ-seq, a team of Whitehead Institute and Broad Institute researchers collaborated on a comprehensive, high-resolution mapping of ψ sites that confirms pseudouridylation, among the most common post-transcriptional modifications, does indeed occur naturally in mRNA.
National Institutes of Health, NIH/National Human Genome Research Institute, Howard Hughes Medical Institute, Broad Institute Funds, Marie Curie IOF, Swiss National Science Foundation

Contact: Matt Fearer
Whitehead Institute for Biomedical Research

Public Release: 15-Sep-2014
Human Molecular Genetics
Researcher develops and proves effectiveness of new drug for spinal muscular atrophy
According to recent studies, approximately one out of every 40 individuals in the United States is a carrier of the gene responsible for spinal muscular atrophy (SMA), a neurodegenerative disease that causes muscles to weaken over time. Now, researchers at the University of Missouri have made a recent breakthrough with the development of a new compound found to be highly effective in animal models of the disease. In April, a patent was filed for the compound for use in SMA.
National Institutes of Health

Contact: Jeff Sossamon
University of Missouri-Columbia

Public Release: 15-Sep-2014
Journal of Biological Chemistry
Drug's effect on Alzheimer's may depend on severity of disease
A cancer drug that has shown promise against Alzheimer's disease in mice and has begun early clinical trials has yielded perplexing results in a novel mouse model of AD that mimics the genetics and pathology of the human disease more closely than any other animal model.
NIH/National Institute on Aging, UIC Center for Clinical and Translational Science

Contact: Sharon Parmet
University of Illinois at Chicago

Public Release: 15-Sep-2014
X-rays unlock a protein's SWEET side
Understanding just how sugar makes its way into the cell could lead to the design of better drugs for diabetes patients and an increase in the amount of fruits and vegetables farmers are able to grow. Stanford University researchers have recently uncovered one of these 'pathways' into the cell by piecing together proteins slightly wider than the diameter of a strand of spider silk.
US Department of Energy, National Institutes of Health, NIH/National Institute of General Medical Sciences

Contact: Tona Kunz
DOE/Argonne National Laboratory

Public Release: 15-Sep-2014
IU study: Combining epilepsy drug, morphine can result in less pain, lower opioid doses
Adding a common epilepsy drug to a morphine regimen can result in better pain control with fewer side effects. Moreover, the combination can reduce the dosage of the opioid needed to be effective, according to a team of pain researchers at Indiana University.
National Institutes of Health, Indiana Spinal Cord and Brain Injury Research Fund

Contact: Eric Schoch
Indiana University

Public Release: 15-Sep-2014
Cells simply avoid chromosome confusion
Reproductive cell division has evolved a simple, mechanical solution to avoid chromosome sorting errors. This natural safeguard prevents incorrect chromosome counts and misalignments that lead to infertility, miscarriage, or congenital conditions.
Wellcome Trust, National Institutes of Health, Packard Fellowship, Ludwig Institute for Cancer Research, Sidney Kimmel Foundation

Contact: Leila Gray
University of Washington Health Sciences/UW Medicine

Public Release: 15-Sep-2014
Proceedings of the National Academy of Sciences
Network measures predict neuropsychological outcome after brain injury
In research published online Sept. 15 in the Early Edition of the Proceedings of the National Academy of Sciences, scientists studied neurological patients with focal brain damage, and found that damage to six hub locations -- identified in a model developed at Washington University using resting state fMRI, functional connectivity analyses, and graph theory -- produced much greater cognitive impairment than damage to other locations.
National Institutes of Health, McDonnell Foundation, Simons Foundation, NIH/National Institutes of Mental Health

Contact: John Riehl
University of Iowa Health Care

Public Release: 15-Sep-2014
Proceedings of the National Academy of Sciences
Neuroscientists identify key role of language gene
Neuroscientists have found that a gene mutation that arose more than half a million years ago may be key to humans' unique ability to produce and understand speech.
Nancy Lurie Marks Family Foundation, Simons Foundation, National Institutes of Health, Wellcome Trust, Foundation pour la Recherche Medicale, Max Planck Society

Contact: Sarah McDonnell
Massachusetts Institute of Technology

Public Release: 15-Sep-2014
American Journal of Pathology
Predicting prostate cancer: Pitt-developed test identifies new methods for treatment
A genetic discovery out of the University of Pittsburgh School of Medicine is leading to a highly accurate test for aggressive prostate cancer and identifies new avenues for treatment.
National Institutes of Health, American Cancer Society, University of Pittsburgh Cancer Institute

Contact: Allison Hydzik
University of Pittsburgh Schools of the Health Sciences

Showing releases 3051-3075 out of 3759.

<< < 118 | 119 | 120 | 121 | 122 | 123 | 124 | 125 | 126 | 127 > >>


Copyright ©2015 by AAAS, the science society.